CHARLA WATSON: Open Payments
NPI 1659770527 · HAMILTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 22 payments from 5 companies in 2025. Trend: 2023 $104 · 2024 $259 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $181 |
| Amgen Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, REXULTI, QULIPTA, REPATHA, AIRSUPRA, OTEZLA, UBRELVY.
Industry payments across AL — which companies pay providers there.
